The United States proteomics market growth is expected to progress at a CAGR of 13.05% during the forecast period, 2022-2028, and is set to project a revenue of $22799.96 million by 2028.

The rising investments in innovative proteomics technologies from organizations, the increasing collaborations and agreements among big market players, and the growing R&D investments are propelling the proteomics market growth in the United States.

To know more about this report, request a free sample copy

In the US, several major biotechnology firms are focusing on human healthcare. Also, these companies are prioritizing the discovery and development of methods to treat, cure, diagnose, and prevent life-threatening and chronic diseases without satisfactory preventive agents or medical therapies at present. In addition, a number of companies are equally focusing on diagnostics and therapeutics. Proteomics entails the use of advanced technologies for identifying and qualifying proteins and detecting diagnostics markers.

The United States proteomics market segmentation includes the analysis of application and components. The components segmentation entails services, instruments, and reagents. The reagents are sub-categorized into immunoassay, X-ray crystallography, microarray, spectroscopy, protein fractionation reagents, chromatography, and electrophoresis.

Spectroscopy is the study of the emission and absorption of light and other radiation by matter. It entails the splitting of electromagnetic/light radiation into its constituent wavelengths called spectrum. Also, spectroscopy tests provide information about the presence of chemical elements and compounds present in the sample, the occurrence of specific degradation types in a sample, and the presence of the type and amount of crystallinity in the sample. In addition, the spectroscopic techniques can be integrated with chemical reactions to perform low, precision level analysis of the number of particular compounds like proteins or formaldehyde in a sample.

Further, the spectroscopic assessment can involve microwave, visible, radio, infrared, X-ray, ultraviolet, or gamma radiation light to identify the sample’s varied properties. It can be used for protein identification, protein structure determination, and protein quantitation.

Immunoassay is a biochemical method that quantifies and identifies unknown analytes in a solution using antibody-antigen reactions. These are utilized in food testing, drug monitoring, drug discovery, and clinical diagnostics. Also, it is a quick and accurate test that can be used in the laboratory and on-site for detecting specific molecules. In addition, it relies on the inherent ability of antibodies to hold on to the specific molecule structure.

Whereas chromatography is an analytical technique conventionally used for splitting a mixture of chemical substances into its individual components for their thorough analysis. The different types of chromatography include affinity chromatography, ion-exchange chromatography, gas chromatography, liquid chromatography, etc., with the same basic principles. The varied components of the mixture travel through the stationary phase at different speeds, resulting in their separation. The nature of the particular stationary and mobile phases determines which substances travel slowly or swiftly. Chromatography is used in proteomics research since it offers high-sensitivity, high-resolution, and high-speed separation of molecules.

Some of the leading firms in the United States proteomics market include Agilent Technologies Inc, Bruker Corporation, PerkinElmer Inc, Thermo Fisher Scientific Inc, Danaher Corporation, Waters Corporation, etc.

Bruker Corporation develops, manufactures, and distributes high-performance scientific instruments and analytical & diagnostic solutions. It caters to pharmaceuticals, applied markets, microbiology, nanotechnology, in-vitro diagnostics, life science research, etc. The company has several major manufacturing and technical centers in North America and Europe, with headquarters in Billerica, Massachusetts.

One of its key products, impact II instrument, is used for analytical performance in forensics, industrial, and synthetic chemistry, biomarker research, and contamination screening with ultra0high resolution Qq-time-of-flight mass spectrometry.

Report Synopsis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.